Sign inJoin waitlistJoin the waitlist

TC

Trevor Crowell

Assistant Professor, Medicine, School of Medicine · National Capital Consortium

Credentials: · · · · ·

History

National Capital Consortium
Present

Infectious Disease
Johns Hopkins University School of Medicine
2024–2026
Johns Hopkins Bloomberg School of Public Health
2015
Internal Medicine
Case Western Reserve University/University Hospitals Cleveland Medical Center
2008–2011
Keck Sch of Med of the Univ of Southern Calif
2004–2008
2004 B.A. Rice University, Houston, TX
2004

Research

Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection
Nature Medicine · 2018 · 291 citations
Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis
Systematic review or meta-analysis · PLoS ONE · 2015 · Last of 6 authors · 253 citations
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind,…
The Lancet · 2018 · 163 citations

Julie Ake
87 papers
MR
Merlin Robb
57 papers
CP
Christina Polyak
55 papers
RN
Rebecca Nowak
33 papers · 33 as a resident
NM
Nelson Michael
31 papers
DC
Donn Colby
26 papers
JA
Jintanat Ananworanich
24 papers
WB
William Blattner
11 papers
PC
Phillip Chan
8 papers · 5 as a resident
Serena Spudich
8 papers
VV
Victor Valcour
8 papers
KM
Kayvon Modjarrad
7 papers

Grants

Understanding Pandemic Evolution Through Networked Data (UPEND)
National Institute of Mental Health · RF1
Contact PI · $3.8M · Henry m. Jackson Fdn for the Adv Mil/Med
2023–2027

Clinical trials

Protocol RV 583 Multinational Observational Cohort of HIV and Other Infections
Principal investigator · Recruiting
Henry M. Jackson Foundation for the Advancement of Military Medicine
2021–2032
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Study chair · Recruiting · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2024–2028
Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2016–2017